DIAGENS
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A diagnostics firm creating rapid molecular tests for infectious diseases and cancer.
DiagnosticsInfectious DiseaseOncology
Technology Platform
Develops molecular diagnostic assays using technologies like PCR and sequencing for pathogen and cancer biomarker detection.
Opportunities
Benefiting from China's push for healthcare modernization and localization of medical devices.
Risk Factors
Intense price competition and evolving regulatory hurdles for product approvals could pressure margins.
Competitive Landscape
Operates in a highly competitive Chinese IVD market with numerous local firms and global giants like Roche and Thermo Fisher.